Estimates were made for the seven countries and territories in the IDF South-East Asia (SEA) Region. All countries except Bhutan had primary data sources, which were used to generate estimates for diabetes in adults aged 20-79 years. A total of 9 data sources from these six countries were used. All data sources that were used to generate estimates are older than five years.
IDF projects that the number of people with diabetes in SEA Region will increase 68% reaching 152 million by 2045 and the prevalence of diabetes will increase 30% reaching 11.3% in 2045. In 2021, 65.3 billion USD was spent on diabetes in SACA Region, representing 6.7% of the total spent worldwide. The proportion of undiagnosed diabetes is third highest in the SEA Region with 51.2%. The proportion of pregnancies affected by hyperglycaemia is the highest among IDF Region with 25.9%. Only 10.1 billion USD was spent on diabetes in SEA Region, representing 1% of the total spent worldwide, despite the region being home to 16.8% of people with diabetes worldwide.
| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 34,882.2 | 71,406.9 | 90,204.5 | 113,300.0 | 151,500.0 |
| Age-adjusted comparative prevalence of diabetes, % | 5.3 | 9.2 | 10.0 | 10.9 | 11.3 |
| People with undiagnosed diabetes, in 1,000s | - | - | 46,230.3 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 51.3 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 23,800.0 | 46,882.8 | 58,500.0 | 76,600.0 |
| Age-adjusted comparative prevalence of IGT, % | - | 3.0 | 5.4 | 5.7 | 5.8 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 95,176.1 | 109,400.0 | 125,400.0 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 8.8 | 9.2 | 9.3 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 1,156,000.0 | 747,367.0 | - | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 21.1 | 18.0 | 20.5 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 25.7 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 76.6 | 111.5 | 132.2 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 244.5 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 6,800,260.9 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 25.9 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 354,578.4 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 344,699.6 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | 4,500.0 | 10,099.4 | 17,675.4 | 21,200.0 |
| Total diabetes-related health expenditure, ID million | - | - | 36,398.3 | 59,282.9 | 71,591.7 |
| Diabetes-related health expenditure per person, USD | - | 0.0 | 112.0 | 22,816.9 | 17,803.6 |
| Diabetes-related health expenditure per person, ID | - | - | 403.5 | 63,785.9 | 49,776.9 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 664,000.0 | 856,000.0 | 1,033,408.9 | 1,182,887.0 | 1,340,000.0 |
| Population of children (0-14 y), in 1,000s | 422,324.0 | - | 416,838.7 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 563,552.2 | - | - |